GDC-0077
Bakeng sa lipatlisiso tsa saense feela, eseng bakeng sa bakuli.
Lintlha tsa Sehlahisoa
Li-tag tsa Sehlahisoa
| Boholo ba Pakete | Ho fumaneha | Theko (USD) |
Lebitso la lik'hemik'hale:
(S) -2-((2-((S)-4-(difluoromethyl)-2-oxooxazolidin-3-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4 ]oxazepin-9-yl)amino)propanamide
SMILES Khouto:
C[C@@H](C(N)=O)NC1=CC=C(C2=NC(N3[C@H](C(F)F)COC3=O)=CN2CCO4)C4=C1
Khoutu ea InChi:
InChI=1S/C18H19F2N5O4/c1-9(16(21)26)22-10-2-3-11-13(6-10)28-5-4-24-7-14(23-17(11) 24)2 5-12(15(19)20)8-29-18(25)27/h2-3,6-7,9,12,15,22H,4-5,8H2,1H3,(H2,21,26 )/t9-,12-/m0/s1
InChi Key:
SGEUNORSOZVTOL-CABZTGNLSA-N
Keyword:
GDC-0077; GDC 0077; GDC0077
Sollubility:DMSO
Polokelo:
Tlhaloso:
GDC-0077 ke PI3K inhibitor e fumanehang ka molomo e nang le ts'ebetso e ka bang teng ea antineoplastic. GDC-0077 e ntšitsoe ho patent WO 2017001645 A1, formula I.
Sepheo: PI3K
